181 related articles for article (PubMed ID: 37351035)
1. Evaluation of changes in Salivary Lactate Dehydrogenase Level for detection of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis Study.
Abedi N; Maleki L; Tarrahi MJ; Khalesi S
Int J Prev Med; 2023; 14():50. PubMed ID: 37351035
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Lactate Dehydrogenase in the Saliva and Tissues of Patients with Head and Neck Squamous Cell Carcinoma.
Mohajertehran F; Ayatollahi H; Jafarian AH; Khazaeni K; Soukhtanloo M; Shakeri MT; Mohtasham N
Rep Biochem Mol Biol; 2019 Jan; 7(2):142-149. PubMed ID: 30805393
[TBL] [Abstract][Full Text] [Related]
3. Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis.
Khijmatgar S; Yong J; Rübsamen N; Lorusso F; Rai P; Cenzato N; Gaffuri F; Del Fabbro M; Tartaglia GM
Jpn Dent Sci Rev; 2024 Dec; 60():32-39. PubMed ID: 38204964
[TBL] [Abstract][Full Text] [Related]
4. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
[TBL] [Abstract][Full Text] [Related]
5. Salivary lactate dehydrogenase as a prognostic marker in oral squamous cell carcinoma patients following surgical therapy.
Pathiyil V; D'Cruz AM
J Exp Ther Oncol; 2017 Sep; 11(2):133-137. PubMed ID: 28976136
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Correlation of serum lactate dehydrogenase and alkaline phosphatase in different histological grades of head and neck squamous cell carcinoma and premalignant lesions.
Bhattacharjee A; Giri S; Roy M; Chakraborty A
J Cancer Res Ther; 2018; 14(5):934-940. PubMed ID: 30197328
[TBL] [Abstract][Full Text] [Related]
8. Estimation of salivary lactate dehydrogenase in oral squamous cell carcinoma, oral leukoplakia, and smokers.
Bhuvaneswari M; Prasad H; Rajmohan M; Sri Chinthu KK; Prema P; Mahalakshmi L; Kumar GS
J Cancer Res Ther; 2022 Dec; 18(Supplement):S215-S218. PubMed ID: 36510967
[TBL] [Abstract][Full Text] [Related]
9. Lactate Dehydrogenase as a Biomarker in Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis.
Mahapatra M; Panda A; Kumar H; Barman D; Talukdar R; Dakshinakabat P
Cureus; 2023 Dec; 15(12):e51008. PubMed ID: 38264399
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Salivary miRNA in Head and Neck Squamous Cell Cancer: Systematic Review and Meta-Analysis.
Kang JW; Eun YG; Lee YC
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209954
[TBL] [Abstract][Full Text] [Related]
11. Gene polymorphisms and prognosis of head and neck squamous cell carcinoma: a systematic review.
Rajabi-Moghaddam M; Abbaszadeh H
Rep Pract Oncol Radiother; 2022; 27(6):1045-1057. PubMed ID: 36632296
[TBL] [Abstract][Full Text] [Related]
12. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.
Mohtasham N; Najafi-Ghobadi K; Abbaszadeh H
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1776. PubMed ID: 36573562
[TBL] [Abstract][Full Text] [Related]
13. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Tissue and Serum Expression Levels of Lactate Dehydrogenase Isoenzymes in Patients with Head and Neck Squamous Cell Carcinoma.
Mohtasham N; Ayatollahi H; Saghravanian N; Zare R; Shakeri MT; Sahebkar A; Mohajertehran F
Anticancer Agents Med Chem; 2019; 19(17):2072-2078. PubMed ID: 31660843
[TBL] [Abstract][Full Text] [Related]
15. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
16. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors?
Elmahgoub F
Evid Based Dent; 2022 Mar; 23(1):30-31. PubMed ID: 35338326
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and proteomic differentials in head and neck squamous cell carcinomas and normal gingival tissue.
Ziebart T; Walenta S; Kunkel M; Reichert TE; Wagner W; Mueller-Klieser W
J Cancer Res Clin Oncol; 2011 Feb; 137(2):193-9. PubMed ID: 20383719
[TBL] [Abstract][Full Text] [Related]
18. Histopathological differentiation of oral squamous cell carcinoma and salivary lactate dehydrogenase: A biochemical study.
D'Cruz AM; Pathiyil V
South Asian J Cancer; 2015; 4(2):58-60. PubMed ID: 25992341
[TBL] [Abstract][Full Text] [Related]
19. A study of salivary lactate dehydrogenase isoenzyme levels in patients with oral leukoplakia and squamous cell carcinoma by gel electrophoresis method.
Joshi PS; Golgire S
J Oral Maxillofac Pathol; 2014 Sep; 18(Suppl 1):S39-44. PubMed ID: 25364177
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
